1. Home
  2. LWAY vs OBIO Comparison

LWAY vs OBIO Comparison

Compare LWAY & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LWAY

Lifeway Foods Inc.

HOLD

Current Price

$22.08

Market Cap

377.8M

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

SELL

Current Price

$5.38

Market Cap

362.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LWAY
OBIO
Founded
1986
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
377.8M
362.4M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
LWAY
OBIO
Price
$22.08
$5.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
★ $33.00
$12.43
AVG Volume (30 Days)
146.8K
★ 287.1K
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.33
33.13
EPS
★ 0.31
N/A
Revenue
★ $103,350,000.00
$33,482,000.00
Revenue This Year
$23.58
N/A
Revenue Next Year
$13.65
$33.03
P/E Ratio
$71.65
★ N/A
Revenue Growth
N/A
★ 1169.22
52 Week Low
$17.31
$3.34
52 Week High
$32.71
$6.50

Technical Indicators

Market Signals
Indicator
LWAY
OBIO
Relative Strength Index (RSI) 42.38 41.96
Support Level $21.25 $3.67
Resistance Level $22.80 $5.78
Average True Range (ATR) 0.69 0.34
MACD 0.28 -0.09
Stochastic Oscillator 60.96 1.70

Price Performance

Historical Comparison
LWAY
OBIO

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: